Calton & Associates’s ASML ASML Stock Holding History

Calton & Associates’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Sell	174 -166	-49%	-$264K	0.05%	280
2026 Q1	$449K	Buy	340 +60	+21%	+$82.2K	0.06%	253
2025 Q4	$300K	Buy	280 +1	+0.4%	+$1.04K	0.04%	325
2025 Q3	$270K	Buy	+279	New	+$219K	0.04%	345
2022 Q1	–	Sell	-334	Closed	-$266K	–	355
2021 Q4	$266K	Buy	334 +20	+6%	+$15.9K	0.07%	289
2021 Q3	$234K	Sell	314 -29	-8%	-$22.8K	0.05%	343
2021 Q2	$235K	Sell	343 -20	-6%	-$13.2K	0.04%	348
2021 Q1	$225K	Sell	363 -143	-28%	-$79.3K	0.04%	353
2020 Q4	$247K	Buy	+506	New	+$213K	0.04%	309
2018 Q2	–	Sell	-1,433	Closed	-$285K	–	298
2018 Q1	$285K	Buy	1,433 +341	+31%	+$67.1K	0.08%	239
2017 Q4	$224K	Buy	+1,092	New	+$193K	0.06%	312

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Calton & Associates's ASML Position: Q2 2026 in Review

Calton & Associates reduced its ASML (ASML) stake by 49% in Q2 2026, selling an estimated $264K and leaving 174 shares worth $346K. The position accounts for 0.05% of the portfolio, ranked #280.

Calton & Associates first reported a position in ASML in Q4 2017 and has held it in 11 quarters since. The position peaked at $449K in Q1 2026. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Calton & Associates held 174 shares of ASML worth $346K as of Q2 2026.
Calton & Associates sold 166 ASML shares in Q2 2026, an estimated $264K.
ASML made up 0.05% of Calton & Associates's portfolio in Q2 2026, its #280 holding.
Calton & Associates first reported a position in ASML in Q4 2017 and has held it in 11 quarters since.
Calton & Associates's ASML position peaked at $449K in Q1 2026.
2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.